Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
This study is ongoing, but not recruiting participants.
Sponsor:
Telik
Information provided by (Responsible Party):
Telik
ClinicalTrials.gov Identifier:
NCT01422486
First received: August 18, 2011
Last updated: March 13, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |